市场趋势
| 短期 | 中期 | ||
| 行业 | Drug Manufacturers - Specialty & Generic (US) | 看跌 | 混合的 |
| Drug Manufacturers - Specialty & Generic (全球的) | 看跌 | 混合的 | |
| 股票 | OptiNose, Inc. | 看涨 | 看涨 |
AIStockmoo 评分
-1.3
| 分析师共识 | -3.0 |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 0.0 |
| 平均 | -1.25 |
|
OptiNose Inc is a specialty pharmaceutical company focuses on the development and commercialization of products for patients treated by ear, nose, and throat (ENT), and allergy specialists. Its first commercial product, XHANCE (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing the proprietary Exhalation Delivery System (EDS) that delivers topically-acting corticosteroid for the treatment of chronic rhinosinusitis with and without nasal polyps. |
|
| 部门 | Healthcare |
| 行业 | Drug Manufacturers - Specialty & Generic |
| 投资方式 | Small Value |
| 内部持股比例 | 6.42% |
| 机构持股比例 | 73.90% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Mvm Partners, Llc | 31 Dec 2024 | 973,684 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 9.00 (Piper Sandler, -3.43%) | 保留 |
| 9.00 (HC Wainwright & Co., -3.43%) | 保留 | |
| 9.00 (Lake Street, -3.43%) | 保留 | |
| 中 | 9.00 (-3.43%) | |
| 平均值 | 9.00 (-3.43%) | |
| 总计 | 3 保留 | |
| 平均价格@调整类型 | 9.15 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| HC Wainwright & Co. | 21 Mar 2025 | 9.00 (-3.43%) | 保留 | 9.15 |
| Piper Sandler | 21 Mar 2025 | 9.00 (-3.43%) | 保留 | 9.15 |
| Lake Street | 20 Mar 2025 | 9.00 (-3.43%) | 保留 | 9.15 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合